Cigna Group $CI Shares Sold by Campion Asset Management

Campion Asset Management cut its holdings in Cigna Group (NYSE:CI) by 3.0% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 1,435 shares of the health services provider’s stock after selling 45 shares during the period. Campion Asset Management’s holdings in Cigna Group were worth $474,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CI. Nuveen LLC acquired a new position in Cigna Group in the 1st quarter valued at $727,905,000. Price T Rowe Associates Inc. MD raised its holdings in Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares during the last quarter. GQG Partners LLC raised its holdings in Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after acquiring an additional 865,092 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Cigna Group by 38.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after acquiring an additional 457,052 shares during the last quarter. Finally, Bank of Nova Scotia raised its holdings in Cigna Group by 163.2% in the 1st quarter. Bank of Nova Scotia now owns 333,435 shares of the health services provider’s stock valued at $109,700,000 after acquiring an additional 206,739 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Up 0.7%

Shares of NYSE CI opened at $286.04 on Monday. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88. The company has a market cap of $76.35 billion, a P/E ratio of 15.61, a P/E/G ratio of 0.84 and a beta of 0.48. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a fifty day moving average price of $292.71 and a 200 day moving average price of $310.49.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the prior year, the firm earned $6.72 EPS. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were issued a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 2.1%. The ex-dividend date was Thursday, September 4th. Cigna Group’s dividend payout ratio is currently 32.97%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Guggenheim restated a “buy” rating and set a $350.00 price objective (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Truist Financial set a $375.00 price objective on Cigna Group in a report on Tuesday, September 2nd. Royal Bank Of Canada restated an “outperform” rating and set a $371.00 price objective on shares of Cigna Group in a report on Thursday, June 26th. Wells Fargo & Company dropped their price objective on Cigna Group from $341.00 to $340.00 and set an “equal weight” rating for the company in a report on Thursday, August 14th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, September 13th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $371.81.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.